Europa · Agencias y tiempo real · MarketScreener

Hansa Biopharma AB Stock

Publicado por MarketScreener · Francia hace 12 h

Oct. 23 Hansa Biopharma Announces Idefirix Paes Late-Breaking Abstract Selected for Oral Presentation in High-Impact Clinical Trials Session At ASN Kidney Week CI ...

Leer el artículo completo en MarketScreener Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketscreener.com)

Hansa Biopharma AB Stock

También te puede interesar

Putin meets with Egyptian President al-Sisi

European gas hits highest level since 2022, up 4.35%

China's CXMT to start advanced AI memory production despite poor yields, sources say

Gold slips on oil-fuelled inflation fears ahead of Fed meeting

Trump says he approves of Brazil's Flavio Bolsonaro coming to US

ArcelorMittal advances €1.3 bln Dunkirk EAF project, progresses Mardyck expansion

Hansa Biopharma AB Stock

Compartir

También te puede interesar

Putin meets with Egyptian President al-Sisi

European gas hits highest level since 2022, up 4.35%

China's CXMT to start advanced AI memory production despite poor yields, sources say

Gold slips on oil-fuelled inflation fears ahead of Fed meeting

Trump says he approves of Brazil's Flavio Bolsonaro coming to US

ArcelorMittal advances €1.3 bln Dunkirk EAF project, progresses Mardyck expansion